123 related articles for article (PubMed ID: 26700144)
21. Telomerase targeted therapy in cancer and cancer stem cells.
Xu Y; He K; Goldkorn A
Clin Adv Hematol Oncol; 2011 Jun; 9(6):442-55. PubMed ID: 21841744
[TBL] [Abstract][Full Text] [Related]
22. Prostate tumor-initiating cells: a new target for telomerase inhibition therapy?
Marian CO; Shay JW
Biochim Biophys Acta; 2009 Apr; 1792(4):289-96. PubMed ID: 19264126
[TBL] [Abstract][Full Text] [Related]
23. Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Dikmen ZG; Ozgurtas T; Gryaznov SM; Herbert BS
Biochim Biophys Acta; 2009 Apr; 1792(4):240-7. PubMed ID: 19419695
[TBL] [Abstract][Full Text] [Related]
24. Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.
Walter K; Rodriguez-Aznar E; Ferreira MSV; Frappart PO; Dittrich T; Tiwary K; Meessen S; Lerma L; Daiss N; Schulte LA; Najafova Z; Arnold F; Usachov V; Azoitei N; Erkan M; Lechel A; Brümmendorf TH; Seufferlein T; Kleger A; Tabarés E; Günes C; Johnsen SA; Beier F; Sainz B; Hermann PC
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201898
[TBL] [Abstract][Full Text] [Related]
25. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.
Koziel JE; Herbert BS
Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551
[TBL] [Abstract][Full Text] [Related]
26. Telomerase redux: ready for prime time?
Larrick JW; Mendelsohn AR
Rejuvenation Res; 2015 Apr; 18(2):185-7. PubMed ID: 25790341
[TBL] [Abstract][Full Text] [Related]
27. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
Kolquist KA; Ellisen LW; Counter CM; Meyerson M; Tan LK; Weinberg RA; Haber DA; Gerald WL
Nat Genet; 1998 Jun; 19(2):182-6. PubMed ID: 9620778
[TBL] [Abstract][Full Text] [Related]
28. Telomerase: central regulator of all of the hallmarks of cancer.
Low KC; Tergaonkar V
Trends Biochem Sci; 2013 Sep; 38(9):426-34. PubMed ID: 23932019
[TBL] [Abstract][Full Text] [Related]
29. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.
Li C; Wu S; Wang H; Bi X; Yang Z; Du Y; He L; Cai Z; Wang J; Fan Z
Oncotarget; 2015 Aug; 6(23):19542-51. PubMed ID: 26143634
[TBL] [Abstract][Full Text] [Related]
30. Regulation and effects of modulation of telomerase reverse transcriptase expression in primordial germ cells during development.
Coussens M; Yamazaki Y; Moisyadi S; Suganuma R; Yanagimachi R; Allsopp R
Biol Reprod; 2006 Nov; 75(5):785-91. PubMed ID: 16899651
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
Horikawa I; Barrett JC
Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
[TBL] [Abstract][Full Text] [Related]
32. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
33. EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.
Heeg S; Hirt N; Queisser A; Schmieg H; Thaler M; Kunert H; Quante M; Goessel G; von Werder A; Harder J; Beijersbergen R; Blum HE; Nakagawa H; Opitz OG
Cancer Sci; 2011 Feb; 102(2):351-60. PubMed ID: 21156006
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain.
Middleman EJ; Choi J; Venteicher AS; Cheung P; Artandi SE
Mol Cell Biol; 2006 Mar; 26(6):2146-59. PubMed ID: 16507993
[TBL] [Abstract][Full Text] [Related]
35. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
36. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
Oh BK; Lee CH; Park C; Park YN
Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
[TBL] [Abstract][Full Text] [Related]
37. Telomerase as a "stemness" enzyme.
Kong F; Zheng C; Xu D
Sci China Life Sci; 2014 Jun; 57(6):564-70. PubMed ID: 24829107
[TBL] [Abstract][Full Text] [Related]
38. Role of the tissue factor pathway in the biology of tumor initiating cells.
Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
[TBL] [Abstract][Full Text] [Related]
39. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
40. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
